Stay up to date with the latest breaking news, analysis and commentary on Mirae Asset Sharekhan. Find live updates, exchanges, stock news, earning news and more.
Dr. Reddy’s Laboratories Ltd and Takeda Pharmaceutical Company Ltd, through its Indian subsidiary Takeda Biopharmaceuticals India Pvt. Ltd has entered into a distribution agreement under which Dr. Reddy’s will promote and distribute Takeda's dengue vaccine, QDENGA, across India’s private market for pediatric and adult vaccination in India. Subject to completion of applicable processes with local authorities, the vaccine is anticipated to become available in the first half of 2027.
At 10.17 am, Dr. Reddy’s Laboratories Ltd was trading at Rs. 1,198.90, up by 2.29%, with a volume of 0.65 lakh shares on the BSE.
L&T Semiconductor Technologies unveils 40 products at SEMICON 2026
18 Sep 2026, 11:44AMDr. Reddy’s, Takeda partner for dengue vaccine distribution
18 Sep 2026, 10:19AML&T wins order for Power Transmission & Distribution Business in Saudi Arabia
29-10-2025 10:13:15The ePlane Company signs MOU with Ramco Systems
27-10-2025 12:42:39Refex Industries gets an order worth Rs. 300 Cr from a mining entity in Jharkhand
24-10-2025 13:57:18Diwali Stocks Picks 2025
